AposHealth
AposHealth develops Apos®, an FDA-cleared foot-worn medical device using AI-supported gait analysis and proprietary Pertupods to treat chronic musculoskeletal pain, including knee osteoarthritis. The company serves patients, clinicians, employers, and health plans across three continents.
- Company typePrivate
- Founded2004
- HeadquartersNew York, United States
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
What AposHealth does
AposHealth is a privately held, New York-based healthcare technology company founded in 2004 that has developed Apos®, an FDA-cleared and CE-marked foot-worn medical device for the non-invasive treatment of chronic musculoskeletal conditions, primarily knee osteoarthritis, with extensions into chronic hip pain, lower back pain, and ankle pain. The device uses proprietary configurable pods (Pertupods) on the sole that introduce controlled microinstabilities during walking, combined with AI-supported gait analysis, to redistribute forces across joints and retrain neuromuscular pathways during a patient's normal daily activity. Treatment is delivered as a personalized program: a certified clinician evaluates the patient, calibrates the device to their unique anatomy and biomechanics, and the patient wears the device approximately one hour per day at home, with periodic re-calibration and clinical follow-up. AposCare teletherapy services extend the model to remote patients through a wholly-owned clinical subsidiary (New York City Physical Therapy, PLLC d/b/a AposCare).
The company's underlying technology rests on three reinforcing layers: (1) a hardware IP base anchored by eight or more U.S. patents with international equivalents covering the Pertupod mechanism, the gait-retraining methodology, the precision mapping system, and adjacent indications; (2) an extensive clinical evidence base of 75+ peer-reviewed publications including a JAMA 2020 randomized study; and (3) an accumulated data asset of 150,000+ treated patients across three continents, which feeds AI-assisted device calibration and clinical decision support. Regulatory and guideline endorsements — FDA clearance, CE marking, NICE recommendation, NHS England MedTech Funding Mandate selection, and EULAR guideline inclusion for knee and hip OA — meaningfully de-risk clinical adoption.
AposHealth generates revenue through a hybrid model combining device-and-treatment-program sales, clinician/provider services, employer MSK benefit programs, health-plan coverage, and government contracts including a five-year VA Federal Supply Schedule contract through February 2027. The go-to-market is sales-led and multi-channel: direct engagement with healthcare providers who prescribe and fit the device, dedicated sales motion to employers and health plans via brokers and consultants, AposCare virtual visits for remote patients, and direct-to-consumer awareness marketing. Patient payment is enabled through FSA/HSA funds, financing plans, and insurance reimbursement where covered. The company employs 51–100 people and is led by Clifford Bleustein, MD, MBA as President and CEO.
AposHealth firmographics
Firmographics- Name
- AposHealth
- Legal name
- Apos US Management, Inc.
- Website
- https://aposhealth.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- AposHealth develops Apos®, an FDA-cleared foot-worn medical device using AI-supported gait analysis and proprietary Pertupods to treat chronic musculoskeletal pain, including knee osteoarthritis. The company serves patients, clinicians, employers, and health plans across three continents.
- Ownership category
- akta.pro rank
AposHealth industry classification
Industry- Product category
- Musculoskeletal Medical Device and Therapy Services
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340), Home Health Care Services (62161)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Services-Home Health Care Services (8082)
- akta.pro primary industry
- Sports & Active Rehabilitation Devices (Adaptive Sports Mobility, Performance Prosthetics) (HLAHAMAJ)
- akta.pro secondary industries
- Foot & Ankle (HLAKALAG), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Orthopedics & Sports Medicine Telemedicine Platforms (HLALAGAO), Assistive Technology, Adaptive Equipment & Home Exercise Program Training In-Home (HSABADAN)
Keywords
Where AposHealth is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
AposHealth business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Medical Device Sales and Treatment Program: AposHealth generates revenue through the sale of its Apos foot-worn medical device and associated treatment program. Patients pay using FSA, HSA, financing plans, or insurance. The treatment program includes gait analysis, personalized device calibration, and ongoing clinical follow-up.
- Healthcare Provider Services: Revenue from physical therapists and clinicians who provide Apos treatment to patients, including evaluation, device fitting, and ongoing treatment supervision.
- Government and Institutional Contracts: Revenue from federal supply schedule contracts such as the VA Federal Supply Schedule contract enabling purchase by federal agencies, tribal organizations, and qualified nonprofit customers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Insurance and FSA/HSA Coverage |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels7 records
AposHealth product offering
Product offeringCore offering
AposHealth sells the Apos® foot-worn medical device, an FDA-cleared and CE-marked system that uses AI-supported gait analysis and proprietary Pertupods to deliver personalized biomechanical treatment for knee osteoarthritis, chronic hip pain, and lower back pain. The offering is complemented by clinician-led fitting, ongoing clinical supervision, and the AposCare teletherapy service that enables remote patient consultations and follow-up. The device is worn at home for approximately one hour daily as part of a structured treatment program paid for via insurance, FSA/HSA, or financing.
Product overview
AposHealth offers the Apos® System, a comprehensive musculoskeletal care solution consisting of a foot-worn medical device (Apos®) with proprietary Pertupods, accompanied by AposCare teletherapy services. The system uses biomechanical redistribution and neuromuscular retraining to address knee osteoarthritis, chronic hip pain, and lower back pain. Patients receive personalized treatment plans including gait analysis, device calibration, and ongoing clinical support through virtual or in-person consultations.
Differentiator
Problem solved
Functional benefit
Brands
- AposCare: Teletherapy and remote care services offered through New York City Physical Therapy, PLLC
Products and services
- Apos® foot-worn medical device FDA-cleared, CE-marked foot-worn medical device that delivers personalized biomechanical treatment for knee osteoarthritis, chronic hip pain, and lower back pain through gait retraining and weight redistribution. The device is fitted by certified clinicians and worn at home for approximately one hour per day as part of a structured treatment program.
- AposCare teletherapy service Teletherapy and remote care service delivered through New York City Physical Therapy, PLLC, providing virtual office visits, remote consultations, and follow-up care for patients undergoing Apos® treatment. Designed to extend AposHealth's clinical reach beyond in-person provider visits.
- Apos® treatment program Clinician-led treatment program combining AI-supported gait analysis, personalized Apos® device calibration, in-person fitting, and ongoing clinical follow-up. Targets patients with knee osteoarthritis, chronic hip pain, lower back pain, and ankle pain and is delivered through certified Apos clinicians and the AposCare teletherapy platform.
- Employer MSK benefits program Enterprise offering that provides AposHealth's MSK treatment program as an employee benefit through employer-sponsored health plans, with focus on reducing surgical interventions, pain medication use, and overall healthcare spend. Designed for HR/benefits leaders and benefits brokers.
- Federal Supply Schedule contract offering Government offering that enables the U.S. Department of Veterans Affairs, tribal organizations, and qualified nonprofit customers to purchase the Apos® device under a five-year Federal Supply Schedule contract for veterans with knee osteoarthritis.
Quantifiable outcome
- 70% pain reduction (vs. 35% in controls) - JAMA 2020 study
- +8 more outcomes
Companies that use AposHealth
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
AposHealth technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature3 records
AposHealth partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Manifest Media - Game Recognizes Game PodcastminorAposHealth partnered with Manifest Media's Game Recognizes Game podcast to launch a bold campaign aimed at revolutionizing musculoskeletal care. The partnership leads a national conversation on MSK recovery, greatness, and Apos treatment through talent and media collaboration.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
AposHealth competitors and assessment
Company assessmentDirect peers
- Hinge Health: Digital MSK platform offering AI-guided exercise therapy, PT coaching, and wearable sensors for back, knee, hip, and other joint pain. Targets the same employer and health-plan channels as AposHealth and represents its largest scaled digital competitor.
- Sword Health: Virtual MSK care platform combining digital exercise therapy with pelvic-floor and women's-health extensions. Competes head-to-head with Apos in employer benefits and value-based MSK contracts with a software-only model.
- Kaia Health: Digital MSK and chronic-pain app providing self-management exercise programs and AI motion tracking. Targets similar employer and payor channels and competes for non-invasive MSK treatment share.
- Vori Health: Hybrid in-person and virtual MSK care practice combining physicians, PTs, and health coaches for back, joint, and muscle conditions. Competes with Apos in the value-based-care and employer-sponsored MSK space.
- RecoveryOne: Virtual physical therapy platform for MSK recovery and prevention, distributed through health plans and employers. Provides digital PT programs that overlap with Apos's gait-retraining and joint-pain focus.
Broad incumbents
- Omada Health: Public/established digital chronic-care company with MSK as one of several conditions (diabetes, hypertension, behavioral health). Competes for the same employer benefit dollars but offers a broader chronic-care platform.
- Stryker: Large orthopedic medical-device manufacturer producing joint implants and surgical equipment. Represents the surgical alternative Apos positions against for knee and hip OA, and a potential acquirer in the orthopedic-device category.
- Zimmer Biomet: Global orthopedic medical-device leader in knee and hip replacements. Competes indirectly as the surgical treatment Apos aims to delay or avoid, and has been expanding into digital and conservative-care MSK solutions.
- Dr. Scholl's (Bayer): Mass-market OTC foot-care and insole brand owned by Bayer. Competes for consumers seeking foot and lower-extremity pain relief at low price points, though without Apos's prescription-grade regulatory clearance and clinical evidence.
Emerging players
- Superfeet: Manufacturer of premium OTC foot orthotics and insoles. Adjacent in the foot-worn biomechanical category, serving similar consumer foot/lower-extremity pain needs at a lower price point and OTC distribution.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
AposHealth social profiles
Digital presenceAposHealth compliance and trust
Trust signalCompliance3 records
AposHealth financial estimates
Financial estimateRevenue estimate
Valuation estimate
AposHealth leadership team
Management profileNumber of profiles
Profiles15 records
AposHealth subsidiaries and ownership
Company hierarchySubsidiaries1 record
AposHealth funding detail
Funding detailFunding overview
Funding rounds5 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AposHealth M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AposHealth
What does AposHealth do?
AposHealth sells the Apos® foot-worn medical device, an FDA-cleared and CE-marked system that uses AI-supported gait analysis and proprietary Pertupods to deliver personalized biomechanical treatment for knee osteoarthritis, chronic hip pain, and lower back pain. The offering is complemented by clinician-led fitting, ongoing clinical supervision, and the AposCare teletherapy service that enables remote patient consultations and follow-up. The device is worn at home for approximately one hour daily as part of a structured treatment program paid for via insurance, FSA/HSA, or financing.
Is AposHealth a public or private company?
AposHealth is a private company. It is classified as venture growth investor backed and is currently operating.
When was AposHealth founded?
AposHealth was founded in 2004. It employs 51 to 100 people.
Where is AposHealth based?
AposHealth is headquartered in New York, United States, in the North America region.
How does AposHealth make money?
Three revenue lines are on record. Medical Device Sales and Treatment Program is the primary driver. The others are healthcare Provider Services and government and Institutional Contracts.
Who are AposHealth's main competitors?
Direct peers on record are Hinge Health, Sword Health, Kaia Health, Vori Health and RecoveryOne. Broad incumbents are Omada Health, Stryker, Zimmer Biomet and Dr. Scholl's (Bayer). Superfeet is listed as an emerging player.
Does AposHealth have an API?
No public API is recorded for AposHealth.
What industry is AposHealth in?
AposHealth's product category is Musculoskeletal Medical Device and Therapy Services. Its primary akta.pro industry code is HLAHAMAJ, Sports & Active Rehabilitation Devices (Adaptive Sports Mobility, Performance Prosthetics), with a secondary code of HLAKALAG, Foot & Ankle. Its NAICS code is 334510 and its SIC code is 3842.